Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
SBM Life Science AB
AB
Active
Org 5590613724
Norra Vallgatan 90, 211 22
Malmö
Wholesale of chemical products
·
NACE 4685
Est. 2016 · 10 years old
16 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of chemical products
/
SBM Life Science AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
266M
200M
133M
67M
0M
2021: 203M
203M
2021
2022: 214M (+5% vs 2021)
214M
+5%
2022
2023: 180M (-16% vs 2022)
180M
-16%
2023
2024: 198M (+10% vs 2023)
198M
+10%
2024
2025: 202M (+2% vs 2024)
202M
+2%
2025
EBITDA
SEK millions
11M
8M
6M
3M
0M
2021: 8M
8M
2021
2022: 9M (+13% vs 2021)
9M
+13%
2022
2023: 4M (-56% vs 2022)
4M
-56%
2023
2024: 4M (0% vs 2023)
4M
0%
2024
2025: 7M (+75% vs 2024)
7M
+75%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
201 668
198 302
179 947
214 273
202 987
Staff expenses
—
—
—
—
—
EBITDA
7 145
3 971
3 837
8 986
7 747
Depreciation & amort.
−105
−107
−110
−115
−121
EBIT
7 040
3 864
3 727
8 871
7 626
Net financials
−1 120
−3 120
−10 439
−8 526
−4 454
Profit before tax
5 920
744
−1 360
4 214
5 211
Tax
−1 437
−170
106
−890
−1 236
Net profit
4 483
574
−1 254
3 324
3 975
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
86 269
122 684
104 790
166 764
86 212
Equity
21 682
17 200
16 626
17 880
14 556
Long-term debt
0
0
0
0
0
Short-term debt
64 587
105 484
88 165
148 884
71 657
Total debt
64 587
105 484
88 165
148 884
71 657
Financial ratios
5-year trend
EBITDA margin
3.5%
This company
15.8%
Market median
This company
Market median
78% below market
2021
2025
Equity ratio
25.1%
This company
38.2%
Market median
This company
Market median
34% below market
2021
2025
Return on equity
20.7%
This company
18.4%
Market median
This company
Market median
13% above market
2021
2025
Net profit margin
2.2%
This company
8.1%
Market median
This company
Market median
73% below market
2021
2025
Asset turnover
2.34×
This company
1.12×
Market median
This company
Market median
109% above market
2021
2025
Debt / equity
2.98×
This company
0.62×
Market median
This company
Market median
381% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
View
PDF
More on SBM Life Science AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
